Predominant p53 mutations in enzootic bovine leukemic cell lines

被引:20
作者
Komori, H
Ishiguro, N
Horiuchi, M
Shinagawa, M
Aida, Y
机构
[1] OBIHIRO UNIV AGR & VET MED,DEPT VET PUBL HLTH,OBIHIRO,HOKKAIDO 080,JAPAN
[2] RIKEN,INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,LAB GENE TECHNOL & SAFETY,TSUKUBA,IBARAKI 305,JAPAN
关键词
BLV; EEL; mutation; gene; p53;
D O I
10.1016/0165-2427(95)05538-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The role of the p53 tumor suppressor gene in bovine lymphosarcomas, a fragment of about 1100 bp corresponding to approximately 97% of the open reading frame of the p53 gene was first amplified from single-strand cDNA originated from calf thymus by polymerase chain reaction (PCR) and sequenced to obtain the bovine wild-type p53 gene. At the amino acid level, the homologies of the bovine p53 gene with the human, mouse, chicken and cat p53 genes were 80.9%, 72.8%, 52.7% and 82.3%, respectively. Moreover, eight bovine leukemic cell lines were studied for alterations in the p53 gene. These lines showed no significant somatic alterations in Southern blot analysis, and expressed 2.5 kb p53-specific transcripts in Northern blot analysis. In mutation analysis using the reverse transcriptase-PCR technique, we detected three missense point mutations in four of these bovine leukemic cell lines, These mutations occurred in the 'hotspots' of the p53 gene. Thus p53 mutations predominantly occur in BLV-transformed cell lines and seem to be necessary for development of enzootic bovine leukosis (EBL).
引用
收藏
页码:53 / 63
页数:11
相关论文
共 37 条
[1]  
AIDA Y, 1993, CANCER RES, V53, P429
[2]   ANALYSIS OF THE GENE CODING FOR THE MURINE CELLULAR TUMOR-ANTIGEN P53 [J].
BIENZ, B ;
ZAKUTHOURI, R ;
GIVOL, D ;
OREN, M .
EMBO JOURNAL, 1984, 3 (09) :2179-2183
[3]   FREQUENT MUTATIONS IN THE P53 TUMOR SUPPRESSOR GENE IN HUMAN LEUKEMIA T-CELL LINES [J].
CHENG, J ;
HAAS, M .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (10) :5502-5509
[4]   A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY [J].
FEINBERG, AP ;
VOGELSTEIN, B .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :6-13
[5]  
GLEBOV OK, 1994, CANCER RES, V54, P3703
[6]   DEFECTS IN A CELL-CYCLE CHECKPOINT MAY BE RESPONSIBLE FOR THE GENOMIC INSTABILITY OF CANCER-CELLS [J].
HARTWELL, L .
CELL, 1992, 71 (04) :543-546
[7]  
HEENEY JL, 1990, LAB INVEST, V62, P339
[8]  
HIGUCHI RG, 1989, NUCLEIC ACIDS RES, V17, P58
[9]   MUTATION IS REQUIRED TO ACTIVATE THE P53 GENE FOR COOPERATION WITH THE RAS ONCOGENE AND TRANSFORMATION [J].
HINDS, P ;
FINLAY, C ;
LEVINE, AJ .
JOURNAL OF VIROLOGY, 1989, 63 (02) :739-746
[10]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53